IRIS
MARCHI, SERENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.717
NA - Nord America 4.448
AS - Asia 2.856
SA - Sud America 652
Continente sconosciuto - Info sul continente non disponibili 301
AF - Africa 151
OC - Oceania 3
Totale 13.128
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.317
GB - Regno Unito 1.598
IT - Italia 1.094
SG - Singapore 938
RU - Federazione Russa 902
CN - Cina 747
BR - Brasile 532
VN - Vietnam 372
IE - Irlanda 358
HK - Hong Kong 233
KR - Corea 165
DE - Germania 161
FR - Francia 158
SE - Svezia 119
BD - Bangladesh 104
IN - India 100
FI - Finlandia 98
CA - Canada 62
UA - Ucraina 55
ZA - Sudafrica 52
AR - Argentina 49
NL - Olanda 37
TR - Turchia 33
MX - Messico 32
AT - Austria 29
CI - Costa d'Avorio 28
IQ - Iraq 25
PL - Polonia 24
CO - Colombia 20
EC - Ecuador 19
ES - Italia 17
ID - Indonesia 17
KE - Kenya 14
MA - Marocco 13
VE - Venezuela 13
BE - Belgio 12
JP - Giappone 12
LT - Lituania 12
NG - Nigeria 12
PK - Pakistan 12
CZ - Repubblica Ceca 11
JM - Giamaica 10
JO - Giordania 9
PH - Filippine 9
UZ - Uzbekistan 9
SA - Arabia Saudita 8
CL - Cile 7
IR - Iran 7
CR - Costa Rica 6
IL - Israele 6
MY - Malesia 6
OM - Oman 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
DZ - Algeria 5
EG - Egitto 5
NP - Nepal 5
AL - Albania 4
CH - Svizzera 4
DK - Danimarca 4
PA - Panama 4
TN - Tunisia 4
AO - Angola 3
AU - Australia 3
ET - Etiopia 3
GM - Gambi 3
GT - Guatemala 3
HN - Honduras 3
KH - Cambogia 3
KZ - Kazakistan 3
LV - Lettonia 3
PE - Perù 3
PY - Paraguay 3
SV - El Salvador 3
TH - Thailandia 3
UY - Uruguay 3
AM - Armenia 2
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
CG - Congo 2
GA - Gabon 2
GH - Ghana 2
HU - Ungheria 2
KG - Kirghizistan 2
LB - Libano 2
MD - Moldavia 2
NI - Nicaragua 2
NO - Norvegia 2
RO - Romania 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GY - Guiana 1
IM - Isola di Man 1
KY - Cayman, isole 1
LK - Sri Lanka 1
Totale 12.817
Salva come PNG Salva come JPEG
Città #
Southend 1.513
Dallas 1.024
Singapore 479
Dublin 352
Ashburn 311
Santa Clara 307
Milan 258
San Jose 258
Moscow 253
Hefei 251
Council Bluffs 235
Hong Kong 219
Chandler 174
Beijing 165
Seoul 165
Siena 163
Fairfield 161
Ho Chi Minh City 114
Rome 107
Los Angeles 105
Woodbridge 96
Seattle 74
Hanoi 70
Houston 68
Dong Ket 66
Lauterbourg 63
The Dalles 63
Wilmington 63
Munich 62
New York 56
Cambridge 54
Florence 49
Helsinki 49
Johannesburg 44
Buffalo 42
Princeton 40
Bengaluru 39
Lappeenranta 39
Ann Arbor 38
Jacksonville 36
São Paulo 33
Abidjan 28
Orem 28
San Diego 27
Shanghai 27
Chicago 26
Columbus 26
Boardman 24
Nuremberg 23
Redondo Beach 23
Montreal 21
Brooklyn 20
Figino 20
Frankfurt am Main 20
Warsaw 20
Phoenix 19
San Mateo 19
Vienna 18
Livorno 17
London 17
Toronto 16
Guangzhou 15
Belo Horizonte 14
Baghdad 13
Brescia 13
Chennai 13
Da Nang 13
Portsmouth 13
Rio de Janeiro 13
Mexico City 12
Bari 11
Bogotá 11
Boydton 11
Brasília 11
San Francisco 11
Abuja 10
Arezzo 10
Baltimore 10
Denver 10
Las Vegas 10
Naples 10
Newark 10
Piscataway 10
Porto Alegre 10
Ankara 9
Bologna 9
Brussels 9
Salt Lake City 9
Stockholm 9
Tokyo 9
Turin 9
Amman 8
Amsterdam 8
Atlanta 8
Changsha 8
Dearborn 8
Dhaka 8
Manchester 8
Nanjing 8
Paris 8
Totale 8.596
Salva come PNG Salva come JPEG
Nome #
Epidemiology of herpes simplex virus type 1 and 2 in Italy: a seroprevalence study from 2000 to 2014 644
The virucidal potential effects of violet-blue light on influenza D virus 574
Elimination of congenital rubella: a seroprevalence study of pregnant women and women of childbearing age in Italy 487
Toxoplasma gondii in women of childbearing age and during pregnancy: seroprevalence study in Central and Southern Italy from 2013 to 2017 466
Pertussis over two decades: Seroepidemiological study in a large population of the Siena Province, Tuscany Region, Central Italy 429
Challenges in the development of egg-independent vaccines for influenza 280
Influenza D virus: Serological evidence in the Italian population from 2005 to 2017 247
Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection 246
Impact of erythrocyte species on assays for influenza serology 245
Exploring the implication of DDX3X in DENV infection: discovery of the first-in-class DDX3X fluorescent inhibitor 232
Measles in pregnancy: a threat for Italian women? 212
A serological investigation in Southern Italy: was SARS-CoV-2 circulating in late 2019? 207
Evaluation of Monkeypox- and Vaccinia virus-neutralizing antibodies in human serum samples after vaccination and natural infection 198
System-oriented optimization of multi-target 2,6-diaminopurine derivatives: Easily accessible broad-spectrum antivirals active against flaviviruses, influenza virus and SARS-CoV-2 197
Influenza Viruses and Vaccines: The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines 196
Surveillance for severe acute respiratory infections among hospitalized subjects from 2015/2016 to 2019/2020 seasons in Tuscany, Italy 196
Evaluation of SARS‐CoV‐2 neutralizing antibodies using a CPE‐based colorimetric live virus micro‐neutralization assay in human serum samples 191
Immunogenicity and safety of COVID-19 booster vaccination: A population-based clinical trial to identify the best vaccination strategy 186
Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples 185
Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination 184
Serologically-Based Evaluation of Cross-Protection Antibody Responses among Different A(H1N1) Influenza Strains 183
Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations 180
Detection of antibodies against influenza D virus in swine veterinarians in Italy in 2004 179
Effects of Influenza Vaccine on the Immune Responses to SARS-CoV-2 Vaccination 179
SARS-CoV-2 and influenza virus coinfections in the Tuscan population during the 2021/2022 influenza season 176
Immunity to measles in Italian children and adolescents: a persistent problem in view of measles elimination 173
Improving the ONE HEALTH approach: a lesson from SARS-CoV-2 pandemic 170
Neutralizing activity of African lineage Zika virus immune sera towards Asian lineage 167
COVID-19 Outbreak and BNT162b2 mRNA Vaccination Coverage in a Correctional Facility during Circulation of the SARS-CoV-2 Omicron BA.1 Variant in Italy 166
Dose-sparing effects of novel adjuvants and aluminum hydroxide on two different vaccines in a neonatal mouse model 162
Haemagglutination inhibition and virus microneutralisation serology assays: use of harmonised protocols and biological standards in seasonal influenza serology testing and their impact on inter-laboratory variation and assay correlation: A FLUCOP collaborative study 161
An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP study 159
Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection 154
Zika virus in west africa: A seroepidemiological study between 2007 and 2012 154
Evaluation of monkeypox‐ and vaccinia‐virus neutralizing antibodies before and after smallpox vaccination: A sero‐epidemiological study 153
Seroepidemiological study of Zika virus in selected West African countries between 2007 and 2012 150
Seroprotection against tetanus in the Italian general population 149
Measles immunity over two decades in two large Italian Regions: How far is the elimination goal? 145
Establishment and validation of a high-throughput micro-neutralization assay for respiratory syncytial virus (subtypes A and B) 143
Evaluation of varicella immunity during pregnancy in apulia region, southern italy 143
SARS-CoV-2 epidemiological trend before vaccination era: a seroprevalence study in Apulia, Southern Italy, in 2020 142
Emerging and Re-emerging Arboviral Diseases as a Global Health Problem 142
Analysis of the SARS-CoV-2 inactivation mechanism using violet-blue light (405 nm) 141
Low prevalence of antibodies against pertussis in pregnant women in Italy 140
Detection of Influenza D Antibodies in Dogs, Apulia Region, Italy, 2016 and 2023 138
Prevalence of Influenza B/Yamagata Viruses From Season 2012/2013 to 2021/2022 in Italy as an Indication of a Potential Lineage Extinction 137
Serological Evidence for Circulation of Influenza D Virus in the Ovine Population in Italy 137
West Nile Virus Seroprevalence in the Italian Tuscany Region from 2016 to 2019 136
null 136
Centenarians, semi and supercentenarians, COVID-19 and Spanish flu: a serological assessment to gain insight into the resilience of older centenarians to COVID-19 134
Validation of a Harmonized Enzyme-Linked-Lectin-Assay (ELLA-NI) Based Neuraminidase Inhibition Assay Standard Operating Procedure (SOP) for Quantification of N1 Influenza Antibodies and the Use of a Calibrator to Improve the Reproducibility of the ELLA-NI With Reverse Genetics Viral and Recombinant Neuraminidase Antigens: A FLUCOP Collaborative Study 131
The neutralizing response to SARS-CoV-2 Omicron variants BA.1 and BA.2 in COVID-19 patients and homologous and heterologous vaccinees 127
Detection of IgM, IgG and SARS-CoV-2 RNA among the personnel of the University of Milan, March through May 2020: The UNICORN study 127
Serum neutralizing activity against b.1.1.7, b.1.351, and p.1 sars-cov-2 variants of concern in hospitalized covid-19 patients 125
Evaluation of immune response to SARS-CoV-2 Omicron sublineages six months after different vaccination regimens in Italy 124
Flu vaccine administration in the period before SARS-CoV-2 infection and its outcomes: An umbrella review 122
The burden of influenza and the role of influenza vaccination in adults aged 50-64 years: A summary of available evidence 118
SARS-CoV-2, influenza, HRSV and other respiratory pathogens during the post-COVID-19 era: Epidemic circulation in Italy in the 2023/2024 season 118
Seroprevalence study of Toscana virus and viruses belonging to the Sandfly fever Naples antigenic complex in central and southern Italy 115
Immunogenicity of Calvenza-03 EIV/EHV® Vaccine in Horses: Comparative In Vivo Study 114
Correlation between microneutralization test and a multiplexed immunoassay for evaluation of monkeypox and vaccinia virus antibodies before and after smallpox vaccination 111
Measles Susceptibility in Apulia: The Italian Mirror? 111
SARS-CoV-2 infection among asymptomatic homebound subjects in Milan, Italy 111
Evaluation of antibody response to SARS-CoV-2 variants after 2 doses of mRNA COVID-19 vaccine in a correctional facility 109
Viricide activity of antimicrobial blue light (405 nm) against the SARS-CoV-2 and influenza virus 106
In vitro virucidal activity of mouthwashes on SARS-CoV-2 103
Seroprevalence of measles antibodies in the Italian general population in 2019–2020 102
The baculovirus expression vector system: a modern technology for the future of influenza vaccine manufacturing 102
SARS-CoV-2 Circulation during the First Year of the Pandemic: A Seroprevalence Study from January to December 2020 in Tuscany, Italy 98
Serological follow-up of SARS-CoV-2 asymptomatic subjects 98
Seroprevalence of antibodies to cytomegalovirus in pregnant women in the Apulia region (Italy) 93
Influenza D Virus Circulation Among Bovines, Swine, Equines, and Wild Boars in Italy: A Sero-Epidemiological Study 84
High Seroprevalence of Chikungunya Virus Antibodies Among Pregnant Women Living in an Urban Area in Benin, West Africa 79
Influenza D Virus: A Potential Threat for Humans? 67
Zika Virus Epidemiology in Selected West African Countries between 2007 and 2012 57
Serum neutralizing activity against SARS-CoV-2 variants in hospitalized COVID-19 patients 21
Impact of ABO Blood System on Immunogenicity and Vaccine Efficacy of COVID‐19 Booster Vaccination—A Population‐Based Study of 3066 Individuals 9
Association Between Immunosuppressive Cell Populations and Immune Response to Influenza Vaccination in Younger and Older Adults 8
Exposure of dogs to influenza A and B viruses 7
Totale 13.128
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.840
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.840
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022421 0 0 88 46 19 24 23 22 35 32 50 82
2022/2023559 32 80 65 64 44 93 26 49 68 14 17 7
2023/2024651 17 27 59 24 17 134 249 21 10 34 7 52
2024/20252.345 37 175 198 164 246 177 87 100 238 103 232 588
2025/20266.055 434 683 1.061 802 843 207 543 172 263 339 274 434
2026/2027772 371 188 213 0 0 0 0 0 0 0 0 0
Totale 13.128